Bio-rad Laboratories share price today

(BIO)

Bio-rad Laboratories share price is $328.36 & ₹27,941.79 as on 24 Dec 2024, 2.30 'hrs' IST

$328.36

▲

0.89

(0.27%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Bio-rad Laboratories share price in Dollar and Rupees. Guide to invest in Bio-rad Laboratories from India. Also see the sentimental analysis on Indian investors investing in Bio-rad Laboratories. Get details on the Indian mutual funds that are investing in Bio-rad Laboratories. Get Analyst recommendations and forecasts along with all the Bio-rad Laboratories's financials.

Bio-rad Laboratories share price movements

Today's Low: $323.70
Today's High: $328.89
$328.36
1.42%
Downside
Day's Volatility :1.58%
Upside
0.16%
52 Weeks Low: $262.12
52 Weeks High: $387.99
$328.36
20.17%
Downside
52 Weeks Volatility :32.44%
Upside
15.37%

Bio-rad Laboratories Returns

Period	Bio-rad Laboratories, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	0.14%	-10.0%	0.0%
6 Months	17.17%	-5.7%	0.0%
1 Year	2.31%	2.8%	0.0%
3 Years	-57.04%	-0.4%	-21.1%

Bio-rad Laboratories Key Statistics

in dollars & INR

Previous Close	$327.47
Open	$325.44
Today's High	$328.885
Today's Low	$323.7
Market Capitalization	$9.2B
Today's Volume	$100.9K
52 Week High	$387.99
52 Week Low	$262.12
Revenue TTM	$2.6B
EBITDA	$483.5M
Earnings Per Share (EPS)	$-28.07
Profit Margin	-30.18%
Quarterly Earnings Growth YOY	5.41%
Return On Equity TTM	-9.79%

How to invest in Bio-rad Laboratories from India?

It is very easy for Indian residents to invest directly in Bio-rad Laboratories from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bio-rad Laboratories stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bio-rad Laboratories or BIO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bio-rad Laboratories or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bio-rad Laboratories shares which would translate to 0.003 fractional shares of Bio-rad Laboratories as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bio-rad Laboratories, in just a few clicks!

Returns in Bio-rad Laboratories for Indian investors in Rupees

Investment Value

₹1,00,000

Bio-rad Laboratories investment value today

Current value as on today

₹1,04,634

Returns

₹4,634

(+4.63%)

Returns from Bio-rad Laboratories Stock

₹2,312 (+2.31%)

Dollar Returns

₹2,322 (+2.32%)

Indian investors sentiment towards Bio-rad Laboratories

-29%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Bio-rad Laboratories on INDmoney from India has reduced in the last 30 days as on Dec 24, 2024. -29% less investors are searching Bio-rad Laboratories in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Bio-rad Laboratories

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	28316	-6071.52	2.43%

Global Institutional Holdings in Bio-rad Laboratories

Vanguard Group Inc
6.81%
BlackRock Inc
5.54%
Van Eck Associates Corporation
4.66%
Veritas Asset Management LLP
3.88%
Arnhold & S. Bleichroeder Advisers, LLC
2.55%
Select Equity Group LP
2.53%

Analyst Recommendation on Bio-rad Laboratories

Buy

60%Buy

40%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Bio-rad Laboratories(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bio-rad Laboratories

What analysts predicted

Upside of 23.14%

Current:

$328.36

Target:

$404.33

Insights on Bio-rad Laboratories

Price Movement
In the last 3 years, BIO stock has moved down by -56.0%
Increasing Revenue
Revenue is up for the last 3 quarters, 610.82M → 649.72M (in $), with an average increase of 3.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -2.16B → 653.17M (in $), with an average increase of 431.5% per quarter
BIO vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 60.8% return, outperforming this stock by 58.4%
BIO vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 110.3% return, outperforming this stock by 166.3%
Price to Sales
ForBIO every $1 of sales, investors are willing to pay $3.6, whereas for Boston Scientific Corp., the investors are paying $8.3 for every $1 of sales.

Bio-rad Laboratories Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$2.3B	↑ 6.02%
Net Income	$361.0M	↑ 214.62%
Net Profit Margin	15.76%	↑ 10.45%

	FY19	Y/Y Change
Revenue	$2.3B	↑ 0.94%
Net Income	$1.8B	↑ 387.17%
Net Profit Margin	76.08%	↑ 60.32%

	FY20	Y/Y Change
Revenue	$2.5B	↑ 10.12%
Net Income	$3.8B	↑ 116.88%
Net Profit Margin	149.83%	↑ 73.75%

	FY21	Y/Y Change
Revenue	$2.9B	↑ 14.81%
Net Income	$4.3B	↑ 11.54%
Net Profit Margin	145.57%	↓ 4.26%

	FY22	Y/Y Change
Revenue	$2.8B	↓ 4.12%
Net Income	$-3.6B	↓ 185.27%
Net Profit Margin	-129.45%	↓ 275.02%

	FY23	Y/Y Change
Revenue	$2.7B	↓ 4.67%
Net Income	$-637.3M	↓ 82.43%
Net Profit Margin	-23.86%	↑ 105.59%

	Q2 FY23	Q/Q Change
Revenue	$681.1M	↑ 0.63%
Net Income	$-1.2B	↓ 1785.35%
Net Profit Margin	-170.64%	↓ 180.83%

	Q3 FY23	Q/Q Change
Revenue	$632.1M	↓ 7.19%
Net Income	$106.3M	↓ 109.14%
Net Profit Margin	16.81%	↑ 187.45%

	Q4 FY23	Q/Q Change
Revenue	$681.2M	↑ 7.76%
Net Income	$349.7M	↑ 229.12%
Net Profit Margin	51.34%	↑ 34.53%

	Q1 FY24	Q/Q Change
Revenue	$610.8M	↓ 10.33%
Net Income	$383.9M	↑ 9.78%
Net Profit Margin	62.85%	↑ 11.51%

	Q2 FY24	Q/Q Change
Revenue	$638.5M	↑ 4.53%
Net Income	$-2.2B	↓ 664.05%
Net Profit Margin	-339.16%	↓ 402.01%

	Q3 FY24	Q/Q Change
Revenue	$649.7M	↑ 1.76%
Net Income	$653.2M	↓ 130.16%
Net Profit Margin	100.53%	↑ 439.69%

	FY18	Y/Y Change
Profit	$1.2B	↑ 3.11%

	FY19	Y/Y Change
Profit	$1.3B	↑ 2.67%

	FY20	Y/Y Change
Profit	$1.4B	↑ 14.39%

	FY21	Y/Y Change
Profit	$1.6B	↑ 14.11%

	FY22	Y/Y Change
Profit	$1.6B	↓ 4.47%

	FY23	Y/Y Change
Profit	$1.4B	↓ 8.68%

	Q2 FY23	Q/Q Change
Profit	$362.5M	↑ 0.02%

	Q3 FY23	Q/Q Change
Profit	$335.7M	↓ 7.39%

	Q4 FY23	Q/Q Change
Profit	$365.9M	↑ 9.0%

	Q1 FY24	Q/Q Change
Profit	$326.5M	↓ 10.78%

	Q2 FY24	Q/Q Change
Profit	$355.7M	↑ 8.96%

	Q3 FY24	Q/Q Change
Profit	$355.9M	↑ 0.05%

	FY18	Y/Y Change
Operating Cash Flow	$285.5M	↑ 174.82%
Investing Cash Flow	$-187.0M	↑ 6.5%
Financing Cash Flow	$-48.7M	↓ 14375.66%

	FY19	Y/Y Change
Operating Cash Flow	$457.9M	↑ 60.39%
Investing Cash Flow	$-208.9M	↑ 11.72%
Financing Cash Flow	$-22.8M	↓ 53.25%

	FY20	Y/Y Change
Operating Cash Flow	$575.3M	↑ 25.65%
Investing Cash Flow	$-60.3M	↓ 71.16%
Financing Cash Flow	$-523.0M	↑ 2198.27%

	FY21	Y/Y Change
Operating Cash Flow	$656.5M	↑ 14.11%
Investing Cash Flow	$-784.4M	↑ 1201.97%
Financing Cash Flow	$-55.4M	↓ 89.4%

	FY22	Y/Y Change
Operating Cash Flow	$194.4M	↓ 70.38%
Investing Cash Flow	$-1.2B	↑ 53.94%
Financing Cash Flow	$973.6M	↓ 1856.44%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$98.1M	↓ 0.05%
Investing Cash Flow	$28.0M	↓ 139.71%
Financing Cash Flow	$-202.7M	↓ 4804.99%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$97.7M	↓ 0.36%
Investing Cash Flow	$-52.0M	↓ 285.78%
Financing Cash Flow	$-26.6M	↓ 86.88%

Bio-rad Laboratories Technicals Summary

Sell

Neutral

Buy

Bio-rad Laboratories is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bio-rad Laboratories Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bio-rad Laboratories, Inc.	-2.3%	17.17%	2.31%	-57.04%	-10.66%
Abbott Laboratories	-3.23%	8.36%	4.65%	-19.19%	30.97%
Stryker Corporation	-4.79%	7.93%	22.54%	35.53%	74.73%
Boston Scientific Corp.	0.68%	15.93%	60.49%	108.4%	98.54%
Edwards Lifesciences Corp.	4.97%	-17.86%	-1.93%	-42.71%	-4.81%
Medtronic Plc	-5.07%	1.23%	-1.09%	-22.05%	-27.7%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bio-rad Laboratories, Inc.	31.53	NA	1.19	10.06	-0.1	0.02	NA	267.46
Abbott Laboratories	34.72	34.72	2.21	4.68	0.15	0.06	0.02	22.94
Stryker Corporation	39.08	39.08	2.55	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.51	73.51	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.87	2.55	0.19	0.11	NA	16.18
Medtronic Plc	24.78	24.78	1.48	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bio-rad Laboratories, Inc.	Buy	$9.2B	-10.66%	31.53	-30.18%
Abbott Laboratories	Buy	$198.1B	30.97%	34.72	13.99%
Stryker Corporation	Buy	$139.0B	74.73%	39.08	16.34%
Boston Scientific Corp.	Buy	$131.1B	98.54%	73.51	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-4.81%	28.88	65.86%
Medtronic Plc	Buy	$103.9B	-27.7%	24.78	12.06%

About Bio-rad Laboratories

bio-rad laboratories (nyse: bio and biob) offers a broad range of innovative tools and services to the life science research and clinical diagnostics markets. founded in 1952, bio-rad has a global team of more than 7,600 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. throughout its existence, bio-rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more. based in hercules, ca, bio-rad has operations worldwide.

Organization	Bio-rad Laboratories
Employees	7700
CEO	Mr. Norman D. Schwartz
Industry	Health Technology

Management People of Bio-rad Laboratories

Name	Title
Mr. Norman D. Schwartz	Chairman & CEO
Mr. Jonathan P. DiVincenzo	President & COO
Mr. Roop K. Lakkaraju CPA	Executive VP & CFO
Ms. Tania DeVilliers	Senior Director, Corporate Controller & Interim Principal Accounting Officer
Mr. Yong Chung	Vice President of Investor Relations
Matthew Werner	Senior Vice President and Chief Compliance & Privacy Officer
Courtney C. Enloe	Executive VP, General Counsel & Secretary
Ms. Colleen Corey	Executive Vice President of Global Human Resources
Mr. Michael Crowley	Executive Vice President of Global Commercial Operations
Lee Boyd	Senior Vice President of Global Commercial Operations - Asia Pacific

Important FAQs about investing in Bio-rad Laboratories from India :

What is Bio-rad Laboratories share price today?

Bio-rad Laboratories share price today stands at $328.36, Open: $325.44 ; Previous Close: $327.47 ; High: $328.89 ; Low: $323.70 ; 52 Week High: $387.99 ; 52 Week Low: $262.12. The stock opens at $325.44, after a previous close of $327.47. The stock reached a daily high of $328.89 and a low of $323.70, with a 52-week high of $387.99 and a 52-week low of $262.12.

Can Indians buy Bio-rad Laboratories shares?

Yes, Indians can invest in the Bio-rad Laboratories (BIO) from India.

With INDmoney, you can buy Bio-rad Laboratories at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bio-rad Laboratories at zero transaction cost.

How can I buy Bio-rad Laboratories shares from India?

It is very easy to buy Bio-rad Laboratories from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bio-rad Laboratories be purchased?

Yes, you can buy fractional shares of Bio-rad Laboratories with INDmoney app.

What are the documents required to start investing in Bio-rad Laboratories stocks?

To start investing in Bio-rad Laboratories, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.